Comparison Study of Immunogenicity and Safety of SIBP’s Measles, Mumps and Rubella (MMR) Vaccine versus WHO prequalified GSK Measles, Mumps and Rubella (MMR) Vaccine

计划入组 1,200 人

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients

计划入组 60 人 · 首次发布于 2025 年 9 月 26 日

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

计划入组 851 人 · 首次发布于 2017 年 12 月 11 日

Measles,Mumps and Rubella Combined Vaccine, Live

measles,mumps and rubella vaccine

Measles and Rubella Combined Vaccine,Live

Malaria Vaccine and Drug Development Center

Colombia

AIM VACCINE

China

Finlay Vaccine Institute

California Reports 52 Measles Cases in 2026, More Than Double 2025 Total, as CDPH Urges Back-to-School Vaccination

U.S. Measles Outbreak Reaches 800 Cases, Marking Largest Since Disease Elimination in 2000

Trump Administration Considers Executive Order Targeting Vaccines and Autism Despite Scientific Consensus